Key result
Universal serological screening of pregnant Latin American women achieved 100% coverage compared to 26% with selective screening, identifying an overall T. cruzi prevalence of 3.96%.
Why the study?
Does universal serological screening improve coverage for T. cruzi infection monitoring compared to selective screening in pregnant Latin American women?
Population
3,839 pregnant Latin American women living in Madrid, Spain
Comparison
Universal serological screening for T. cruzi… vs Selective serological screening
Design
Cohort
Authors
Loading...
Universal screening may enhance T. cruzi detection coverage in pregnant Latin American women; leaves open impact on vertical transmission.
Observational (n=3,839)
Yes
Does universal serological screening improve coverage for T. cruzi infection monitoring compared to selective screening in pregnant Latin American women?
Absolute Event Rate: 100% vs 26%
Universal screening of pregnant Latin American women is necessary to achieve full coverage for detecting T. cruzi infection and preventing vertical transmission.
Flóres-Chávez et al. (2011) conducted an observational in Chagas disease (n=3,839). Universal serological screening vs. Selective serological screening was evaluated on Screening coverage. Universal serological screening of pregnant Latin American women achieved 100% coverage compared to 26% with selective screening, identifying an overall T. cruzi prevalence of 3.96%.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: